Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 09:36 am Sale | 13G | HILLEVAX INC HLVX | Deep Track Capital LP | 0 0.000% | -2,900,000 (Position Closed) | View |
2024-11-14 09:00 am Sale | 13G | HILLEVAX INC HLVX | Flynn James E | 1,882,654 3.780% | -2,121,577 (-52.98%) | View |
2024-07-22 9:02 pm Purchase | 13G | HILLEVAX INC HLVX | TANG CAPITAL PARTNERS LP | 4,712,954 9.500% | 4,712,954 (New Position) | View |
2024-05-31 2:00 pm Purchase | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund L.P. | 10,639,562 21.400% | 833,090 (+8.50%) | View |
2024-02-14 6:46 pm Purchase | 13G | HILLEVAX INC HLVX | Lightspeed Venture Partners Select IV L.P. | 2,313,432 4.800% | 400,000 (+20.90%) | View |
2024-02-14 5:01 pm Sale | 13G | HILLEVAX INC HLVX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,760,019 (Position Closed) | View |
2024-02-14 08:45 am Unchanged | 13G | HILLEVAX INC HLVX | Deep Track Capital LP | 2,900,000 5.990% | 0 (Unchanged) | View |
2024-02-12 5:27 pm Purchase | 13G | HILLEVAX INC HLVX | Flynn James E | 4,004,231 8.270% | 1,310,130 (+48.63%) | View |
2024-02-12 4:31 pm Unchanged | 13G | HILLEVAX INC HLVX | Carlyle Group Inc. CG | 1,838,486 3.800% | 0 (Unchanged) | View |
2023-09-29 4:15 pm Purchase | 13G | HILLEVAX INC HLVX | Deep Track Capital LP | 2,900,000 6.140% | 2,900,000 (New Position) | View |
2023-09-27 10:26 am Purchase | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund L.P. | 9,806,472 20.200% | 25,000 (+0.26%) | View |
2023-05-05 4:12 pm Purchase | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund L.P. | 9,781,472 25.000% | 144,240 (+1.50%) | View |
2023-02-14 4:45 pm Purchase | 13G | HILLEVAX INC HLVX | RA CAPITAL MANAGEMENT L.P. | 1,760,019 5.300% | 1,760,019 (New Position) | View |
2023-02-10 4:16 pm Purchase | 13G | HILLEVAX INC HLVX | Carlyle Group Inc. CG | 1,838,486 5.500% | 1,838,486 (New Position) | View |
2023-02-10 09:33 am Purchase | 13G | HILLEVAX INC HLVX | Flynn James E | 2,694,101 8.080% | 76,153 (+2.91%) | View |
2022-09-08 1:19 pm Purchase | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund L.P. | 9,637,232 28.800% | 513,660 (+5.63%) | View |
2022-05-13 4:31 pm Purchase | 13G | HILLEVAX INC HLVX | Lightspeed Venture Partners Select IV L.P. | 1,913,432 5.700% | 1,913,432 (New Position) | View |
2022-05-13 4:31 pm Purchase | 13G | HILLEVAX INC HLVX | Abingworth LLP | 1,838,486 5.500% | 1,838,486 (New Position) | View |
2022-05-09 06:08 am Purchase | 13D | HILLEVAX INC HLVX | TAKEDA PHARMACEUTICAL CO LTD TAK | 6,724,000 17.100% | 6,724,000 (New Position) | View |
2022-05-06 4:15 pm Purchase | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund L.P. | 9,123,572 27.300% | 9,123,572 (New Position) | View |